Step Pharma, Sas
Clinical trials sponsored by Step Pharma, Sas, explained in plain language.
-
New hope for tough lymphomas: experimental drug STP938 enters human trials
Disease control Recruiting nowThis study tests a new drug called STP938 in adults with B-cell or T-cell lymphoma that has returned or not responded to at least two prior treatments. The goal is to find a safe dose and see if the drug can shrink tumors. About 180 people will take part in this early-phase trial…
Phase: PHASE1, PHASE2 • Sponsor: Step Pharma, SAS • Aim: Disease control
Last updated Apr 24, 2026 16:12 UTC
-
New drug STP938 enters human trials for Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests a new drug called STP938 in adults with advanced solid tumors that have not responded to other treatments. The goal is to find a safe dose and see how the body processes the drug. A special part of the study will focus on a type of ovarian cancer that…
Phase: PHASE1 • Sponsor: Step Pharma, SAS • Aim: Disease control
Last updated Apr 24, 2026 16:06 UTC
-
New hope for patients failed by standard blood disorder treatment
Disease control Recruiting nowThis early-stage trial is testing a new oral medication called STP938 for adults with high-risk essential thrombocythemia, a blood disorder causing dangerously high platelet counts. The study focuses on patients who can't tolerate or don't respond to the standard treatment, hydro…
Phase: PHASE1 • Sponsor: Step Pharma, SAS • Aim: Disease control
Last updated Apr 20, 2026 16:18 UTC